Internal Reference Number: FOI_9608
Date Request Received: 14/08/2026 00:00:00
Date Request Replied To: 07/09/2026 00:00:00
This response was sent via: By Email
Request Summary: Gastric and Gastro-oesophageal Junction (GOJ) Adenocarcinoma
Request Category: Companies
| Question Number 1: Gastric and Gastro-oesophageal Junction (GOJ) Adenocarcinoma 鈥� Data Request (Last 12 Months) How many patients have been diagnosed with locally advanced unresectable or metastatic gastric adenocarcinoma in your Trust in the last 12 months? | |
| Answer To Question 1: <=5 | |
| Question Number 2: How many patients have been diagnosed with locally advanced unresectable or metastatic gastroesophageal junction (GOJ) adenocarcinoma in your Trust in the last 12 months? | |
| Answer To Question 2: <=5, please note we are unable to differentiate between gastric adenocarcinoma and GOJ adenocarcinoma with coding | |
| Question Number 3: Of the patients from Questions 1 and 2 (locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma), how many have been treated with each of the following regimens in your Trust? a. Zolbetuximab + chemotherapy b. Pembrolizumab + chemotherapy c. Nivolumab + chemotherapy d. Paclitaxel + ramucirumab e. Other chemotherapy (including but not limited to FLOT, FOLFOX, CAPOX, ECX, FOLFIRI f. Best supportive care | |
| Answer To Question 3: a. Zolbetuximab + chemotherapy - 0 b. Pembrolizumab + chemotherapy - less than 5 c. Nivolumab + chemotherapy - 0 d. Paclitaxel + ramucirumab - 0 e. Other chemotherapy (including but not limited to FLOT, FOLFOX, CAPOX, ECX, FOLFIRI) - 0 f. Best supportive care - less than 5 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
